Also indexed as: Raynaud’s Syndrome
Raynaud’s disease is a condition caused by constriction and spasms of small arteries,
primarily in the hands after exposure to cold. Frequently, white or bluish discoloration of
the hands (and sometimes toes, cheeks, nose, or ears) will occur after exposure to cold or
emotional stress. The cause of Raynaud’s disease is unknown. A condition called
Raynaud’s phenomenon causes similar symptoms, but it is the result of connective tissue
disease or exposure to certain chemicals. The same natural remedies are used to treat both
disorders.
Checklist for
Raynaud’s disease
What are the symptoms of Raynaud’s disease? Fingers
(generally not the thumb) or other affected parts of the body may feel numb or cold during an
episode, and later, after warming, may become bright red with a throbbing painful
sensation.
How is it treated? People with Raynaud’s disease are
commonly advised to dress warmly during the winter and to avoid tobacco use and unnecessary
exposure to cold, especially of the affected parts. Conventional treatment also includes
medicines such as calcium channel blockers
(e.g., nifedipine,
diltiazem) and sympatholytic agents (i.e., drugs that interfere with the effects of
certain types of nerve transmission, including reserpine,
prazosin, doxazosin,
terazosin, methyldopa, guanethidine, and
phenoxybenzamine). In severe cases, sympathectomy (surgical interruption of sympathetic nerve
pathways) may be recommended.
Lifestyle changes that may be helpful: Dressing warmly and
wearing gloves or mittens often help prevent attacks of Raynaud’s disease. Individuals
with Raynaud’s disease should not smoke, because nicotine decreases blood flow to the
extremities. Women with Raynaud’s disease should not use birth control pills, as this method of contraception can
adversely affect circulation.
Nutritional supplements that may be helpful: In a double-blind
trial, supplementation with 12 large capsules of fish oil
per day (providing 4 grams of eicosapentaenoic acid [EPA] per day) for 6 or 12 weeks reduced
the severity of blood-vessel spasm in 5 of 11 people with Raynaud’s
phenomenon.1 Fish oil was effective in people with primary Raynaud’s disease,
but not in those whose symptoms were secondary to another disorder.
Inositol hexaniacinate—a variation on the B
vitamin niacin—has been used with some success for relieving symptoms of Raynaud’s
disease.2 In one study, 30 people with Raynaud’s disease taking 4 grams of
inositol hexaniacinate each day for three months showed less spasm of their
arteries.3 Another study, involving six people taking 3 grams per day of inositol
hexaniacinate, again showed that this supplement improved peripheral circulation.4
People taking this supplement in these amounts should be under the care of a doctor.
Fatty acids in evening primrose oil (EPO)
inhibit the formation of biochemical messengers (prostaglandins) that promote blood vessel
constriction. A double-blind trial of 21 people with Raynaud’s disease found that,
compared with placebo, supplementation with EPO reduced the number and severity of attacks
despite the fact that blood flow did not appear to increase.5 Researchers have used
3,000–6,000 mg of EPO per day.
In one study, 12 people with Raynaud’s disease were given L-carnitine (1 gram three times a day) for 20 days.6
After receiving L-carnitine, these people showed less blood-vessel spasm in their fingers in
response to cold exposure.
Abnormalities of magnesium metabolism have been
reported in people with Raynaud’s disease.7 Symptoms similar to those seen
with Raynaud’s disease occur in people with magnesium deficiency,8 probably
because a deficiency of this mineral results in spasm of blood vessels.9 Some
doctors recommend that people with Raynaud’s disease supplement with 200–600 mg of
magnesium per day, although no clinical trials support this treatment.
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
Herbs that may be helpful: Ginkgo biloba has been reported to improve the
circulation in small blood vessels.10 For that reason, some doctors recommend
ginkgo for people with Raynaud’s disease. One preliminary trial found that 160 mg of
standardized ginkgo extract per day reduced pain in people with Raynaud’s
disease.11 Larger clinical trials are needed to confirm ginkgo’s
effectiveness for this condition. Ginkgo is often used as a standardized extract (containing
24% ginkgo flavone glycosides and 6% terpene lactones). Doctors who recommend use of ginkgo
often suggest that people take 120–160 mg per day.
Are there any side effects or interactions? Refer to the individual herb for
information about any side effects or interactions.
References:
1. Digiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in
patients with Raynaud’s phenomenon: a double-blind, controlled, prospective study.
Am J Med 1989;86:158–64.
2. Aylward M. Hexopal in Raynaud’s disease. J Int Med Res
1979;7:484–91.
3. Holti G. An experimentally controlled evaluation of the effect of
inositol nicotinate upon the digital blood flow in patients with Raynaud’s phenomenon.
J Int Med Res 1979;7:473–83.
4. Ring EF, Bacon PA. Quantitative thermographic assessment of inositol
nicotinate therapy in Raynaud’s phenomenon. J Int Med Res
1977;5:217–22.
5. Belch JJF, Shaw B, O’Dowd A, et al. Evening primrose oil
(Efamol) in the treatment of Raynaud’s phenomenon: A double-blind study. Throm
Haemost 1985;54(2):490–4.
6. Gasser P, Martina B, Dubler B. Reaction of capillary blood cell
velocity in nailfold capillaries to L-carnitine in patients with vasospastic disease.
Drugs Exptl Clin Res 1997;23:39–43.
7. Leppert J, Aberg H, Levin K, et al. The concentration of magnesium in
erythrocytes in female patients with primary Raynaud’s phenomenon; fluctuation with the
time of year. Angiology 1994;45:283–8.
8. Smith WO, Hammarsten JF, Eliel LP. The clinical expression of
magnesium deficiency. JAMA 1960;174:77–8.
9. Turlapaty P, Altura BM. Magnesium deficiency produces spasms of
coronary arteries; relationship to etiology of sudden death ischemic heart disease.
Science 1980;208:198–200.
10. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet
1992;340:1136–9 [review].
11. Clement JL, Livecchi G, Jimenez C, et al. Modifications vasomotrices
des extrémités lors l’exposition à des conditions thermiques
défavorables. Méthodologie et résultant de l’étude de
l’extrait de Ginkgo biloba. Acutal Angiol 1982;7:3–8.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|